🇺🇸 FDA
Patent

US 7150871

Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6

granted A61KA61K38/39A61P

Quick answer

US patent 7150871 (Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6) held by The Regents of the University of California expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/39, A61P, A61P1/16, A61P11/00